Biofrontera AG - Laporan Laba Rugi (TTM)

Biofrontera AG
DE ˙ XTRA ˙ DE0006046113
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Biofrontera AG menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
Revenue 33 30 29 27 28 29 30 31 32 26 25 28 29 32 30 22 18 22 24
Change (%) -8.14 -3.28 -6.91 2.44 2.85 3.78 3.00 4.72 -20.12 -2.98 13.92 0.64 12.64 -6.47 -28.15 -16.14 19.21 9.48
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 3 4 4 4 4 4 4 5 5 5 5 6 6 6 6 5 5 5 6
Change (%) 29.95 2.88 11.52 -9.27 6.30 5.37 13.27 8.33 -5.97 2.92 13.46 2.72 9.41 -0.37 -15.10 -8.14 9.81 5.95
% of Revenue 8.24 11.65 12.39 14.85 13.15 13.59 13.80 15.18 15.70 18.48 19.61 19.53 19.93 19.36 20.62 24.37 26.69 24.59 23.79
Gross Operating Profit 30 27 26 23 24 25 26 26 27 21 20 23 23 26 24 16 13 16 18
Change (%) -11.56 -4.09 -9.52 4.48 2.32 3.53 1.35 4.08 -22.76 -4.32 14.03 0.14 13.45 -7.93 -31.55 -18.71 22.64 10.64
% of Revenue 91.76 88.35 87.61 85.15 86.85 86.41 86.20 84.82 84.30 81.52 80.39 80.47 80.07 80.64 79.38 75.63 73.31 75.41 76.21
SG&A 33 28 26 29 28 34 29 24 18 12 13 13 13 13 12 11 12 17 17
Change (%) -15.18 -5.71 10.59 -2.02 19.55 -13.78 -17.78 -23.42 -33.07 7.09 2.32 0.39 -0.82 -9.05 -5.56 4.68 40.75 1.10
% of Revenue 98.60 91.05 88.76 105.45 100.85 117.23 97.40 77.75 56.86 47.64 52.58 47.23 47.12 41.48 40.34 53.02 66.18 78.14 72.16
R&D 5 5 5 5 6 7 7 7 7 7 7 8 8 8 8 8 6 5 4
Change (%) -0.73 0.13 10.97 10.92 18.76 4.05 -0.97 2.98 -4.15 3.38 7.61 6.24 -6.87 -1.16 -0.31 -19.96 -13.51 -16.35
% of Revenue 14.60 15.78 16.34 19.47 21.09 24.35 24.41 23.47 23.08 27.69 29.51 27.88 29.43 24.33 25.71 35.67 34.05 24.70 18.87
OpEx 40 36 34 38 38 45 41 36 31 24 25 27 28 27 26 25 23 28 27
Change (%) -10.38 -4.09 10.74 -0.99 18.13 -9.30 -11.60 -13.96 -21.64 5.17 6.00 2.60 -0.55 -4.82 -6.27 -5.86 19.69 -1.34
% of Revenue 121.44 118.49 117.49 139.77 135.09 155.17 135.61 116.40 95.64 93.82 101.70 94.64 96.48 85.17 86.67 113.06 126.92 127.43 114.82
Operating Income -7 -6 -5 -11 -10 -16 -11 -5 1 2 -0 2 1 5 4 -3 -5 -6 -4
Change (%) -20.81 -8.48 111.67 -9.62 61.70 -33.01 -52.57 -127.84 13.24 -126.71 -458.82 -33.84 373.84 -15.90 -170.41 72.84 21.44 -40.83
% of Revenue -21.44 -18.49 -17.49 -39.77 -35.09 -55.17 -35.61 -16.40 4.36 6.18 -1.70 5.36 3.52 14.83 13.33 -13.06 -26.92 -27.43 -14.82
Interest Expense -2 -3 -4 -3 -2 -4 -3 -2 -2 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Change (%) 42.00 17.95 -6.47 -45.14 99.57 -23.01 -16.97 -24.43 -90.93 -30.06 -47.37 -28.33 -65.12 -6.67 -0.00 -21.43 -0.00 -27.27
% of Revenue -6.57 -10.15 -12.38 -12.44 -6.66 -12.92 -9.59 -7.73 -5.58 -0.63 -0.46 -0.21 -0.15 -0.05 -0.05 -0.06 -0.06 -0.05 -0.03
Net Income -17 -13 -12 -16 -16 38 15 10 11 -44 -20 -11 -9 -0 0 -3 -0 -4 -1
Change (%) -22.65 -4.78 31.63 -4.01 -344.56 -60.61 -30.80 6.68 -496.36 -55.76 -45.93 -18.56 -95.71 -207.86 -745.23 -86.10 1,118.49 -77.84
% of Revenue -50.97 -42.92 -42.25 -59.74 -55.98 133.11 50.53 33.95 34.58 -171.60 -78.25 -37.14 -30.06 -1.14 1.32 -11.85 -1.96 -20.08 -4.06

Source: Capital IQ

Other Listings
GB:0DOL
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista